Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2002-3-19
pubmed:abstractText
Recent evidence suggests that the prion protein (PrP) is a copper binding protein. The N-terminal region of human PrP contains four sequential copies of the highly conserved octarepeat sequence PHGGGWGQ spanning residues 60-91. This region selectively binds Cu2+ in vivo. In a previous study using peptide design, EPR, and CD spectroscopy, we showed that the HGGGW segment within each octarepeat comprises the fundamental Cu2+ binding unit [Aronoff-Spencer et al. (2000) Biochemistry 40, 13760-13771]. Here we present the first atomic resolution view of the copper binding site within an octarepeat. The crystal structure of HGGGW in a complex with Cu2+ reveals equatorial coordination by the histidine imidazole, two deprotonated glycine amides, and a glycine carbonyl, along with an axial water bridging to the Trp indole. Companion S-band EPR, X-band ESEEM, and HYSCORE experiments performed on a library of 15N-labeled peptides indicate that the structure of the copper binding site in HGGGW and PHGGGWGQ in solution is consistent with that of the crystal structure. Moreover, EPR performed on PrP(23-28, 57-91) and an 15N-labeled analogue demonstrates that the identified structure is maintained in the full PrP octarepeat domain. It has been shown that copper stimulates PrP endocytosis. The identified Gly-Cu linkage is unstable below pH approximately 6.5 and thus suggests a pH-dependent molecular mechanism by which PrP detects Cu2+ in the extracellular matrix or releases PrP-bound Cu2+ within the endosome. The structure also reveals an unusual complementary interaction between copper-structured HGGGW units that may facilitate molecular recognition between prion proteins, thereby suggesting a mechanism for transmembrane signaling and perhaps conversion to the pathogenic form.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10026288, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10051591, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10098399, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10226041, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10373359, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10395584, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10471308, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10548526, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10642183, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10713045, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10716185, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10742195, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10828191, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10838090, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10985358, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-10988071, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-11050225, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-11076515, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-11085945, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-11164938, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-11278306, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-11278539, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-11369504, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-11413003, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-11434776, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-11438695, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-11493001, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-1683708, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-7864852, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-8202492, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-8962161, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-9356250, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-9391046, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-9414160, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-9585530, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-9644969, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-9811807, http://linkedlifedata.com/resource/pubmed/commentcorrection/11900542-9837873
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0006-2960
pubmed:author
pubmed:issnType
Print
pubmed:day
26
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3991-4001
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Molecular features of the copper binding sites in the octarepeat domain of the prion protein.
pubmed:affiliation
Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 95064, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S.